{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:04:14Z","timestamp":1793462654994,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008550","name":"Diabetesfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006129","name":"Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006354","name":"Berth von Kantzows Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006354","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Strategic Research Program for Diabetes"},{"DOI":"10.13039\/501100011727","name":"Stockholm l\u00e4ns landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims\/hypothesis<\/jats:title>\n                <jats:p>Charcot foot is a complication of diabetes mellitus that has potentially disastrous consequences. Although it was first described in 1868 and found to be associated with diabetes in 1936, there is still uncertainty about the risk factors affecting the development of the condition. Here, we aim to identify risk factors for Charcot foot in a nationwide cohort study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective register-based cohort study was performed for the period 2001\u20132016, using nationwide registries. Individuals with diabetes and Charcot foot were identified and matched by diabetes type and with similar diabetes duration with individuals with diabetes but not Charcot foot. Logistic regression analyses were used to identify risk factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 3397 participants with diabetes mellitus and Charcot foot and 27,662 control participants with diabetes but without Charcot foot were included. HbA<jats:sub>1c<\/jats:sub>, duration of diabetes, micro- and macroalbuminuria, retinopathy and atherosclerosis (general and peripheral) were identified as risk factors for Charcot foot in participants with type 1 diabetes and participants with type 2 diabetes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions\/interpretation<\/jats:title>\n                <jats:p>In the most extensive study on Charcot foot to date, we identified distinctive and common risk factors associated with the development of Charcot foot in individuals with type 1 diabetes and type 2 diabetes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00125-024-06271-9","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T21:02:30Z","timestamp":1726261350000},"page":"2702-2710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Risk factors for Charcot foot development in individuals with diabetes mellitus"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8196-9838","authenticated-orcid":false,"given":"Georgios","family":"Tsatsaris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5597-2593","authenticated-orcid":false,"given":"Neda","family":"Rajamand Ekberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2071-5866","authenticated-orcid":false,"given":"Tove","family":"Fall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6914-3902","authenticated-orcid":false,"given":"Sergiu-Bogdan","family":"Catrina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"6271_CR1","first-page":"161","volume":"1","author":"JM Charcot","year":"1868","unstructured":"Charcot JM (1868) Sur quelques arthropathies qui paraissent d\u00e9pendre d\u2019une l\u00e9sion du cerveau ou de la moelle \u00e9pini\u00e8re. Arch Physiol Norm Path 1:161\u2013171","journal-title":"Arch Physiol Norm Path"},{"key":"6271_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1001\/archinte.1936.00170060069004","volume":"57","author":"WR Jordan","year":"1936","unstructured":"Jordan WR (1936) Neuritic manifestations in diabetes mellitus. Arch Intern Med 57:307\u2013366. https:\/\/doi.org\/10.1001\/archinte.1936.00170060069004","journal-title":"Arch Intern Med"},{"issue":"7","key":"6271_CR3","doi-asserted-by":"publisher","first-page":"390","DOI":"10.7547\/87507315-92-7-390","volume":"92","author":"DG Armstrong","year":"2002","unstructured":"Armstrong DG, Peters EJG (2002) Charcot\u2019s arthropathy of the foot. J Am Podiatr Med Assoc 92(7):390\u2013394. https:\/\/doi.org\/10.7547\/87507315-92-7-390","journal-title":"J Am Podiatr Med Assoc"},{"issue":"1","key":"6271_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1757-1146-6-30","volume":"6","author":"TE Milne","year":"2013","unstructured":"Milne TE, Rogers JR, Kinnear EM et al (2013) Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot Neuro-Arthropathy: a systematic review. J Foot Ankle Res 6(1):30. https:\/\/doi.org\/10.1186\/1757-1146-6-30","journal-title":"J Foot Ankle Res"},{"issue":"6","key":"6271_CR5","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/dme.12754","volume":"32","author":"WJ Jeffcoate","year":"2015","unstructured":"Jeffcoate WJ (2015) Charcot foot syndrome. Diabet Med 32(6):760\u2013770. https:\/\/doi.org\/10.1111\/dme.12754","journal-title":"Diabet Med"},{"issue":"5","key":"6271_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/107110079401500502","volume":"15","author":"MS Myerson","year":"1994","unstructured":"Myerson MS, Henderson MR, Saxby T, Short KW (1994) Management of midfoot diabetic neuroarthropathy. Foot Ankle Int 15(5):233\u2013241. https:\/\/doi.org\/10.1177\/107110079401500502","journal-title":"Foot Ankle Int"},{"issue":"9","key":"6271_CR7","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.2337\/dc11-0844","volume":"34","author":"LC Rogers","year":"2011","unstructured":"Rogers LC, Frykberg RG, Armstrong DG et al (2011) The charcot foot in diabetes. Diabetes Care 34(9):2123\u20132129. https:\/\/doi.org\/10.2337\/dc11-0844","journal-title":"Diabetes Care"},{"issue":"3","key":"6271_CR8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1302\/0301-620x.86b3.14593","volume":"86","author":"SA Herbst","year":"2004","unstructured":"Herbst SA, Jones KB, Saltzman CL (2004) Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J Bone Joint Surg Br 86(3):378\u2013383. https:\/\/doi.org\/10.1302\/0301-620x.86b3.14593","journal-title":"J Bone Joint Surg Br"},{"issue":"2","key":"6271_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1053\/j.jfas.2004.01.001","volume":"43","author":"KD Foltz","year":"2004","unstructured":"Foltz KD, Fallat LM, Schwartz S (2004) Usefulness of a brief assessment battery for early detection of Charcot foot deformity in patients with diabetes. J Foot Ankle Surg 43(2):87\u201392. https:\/\/doi.org\/10.1053\/j.jfas.2004.01.001","journal-title":"J Foot Ankle Surg"},{"issue":"4","key":"6271_CR10","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.2337\/dc20-2590","volume":"44","author":"OL Svendsen","year":"2021","unstructured":"Svendsen OL, Rabe OC, Winther-Jensen M, Allin KH (2021) How common is the rare Charcot foot in patients with diabetes? Diabetes Care 44(4):e62\u2013e63. https:\/\/doi.org\/10.2337\/dc20-2590","journal-title":"Diabetes Care"},{"issue":"12","key":"6271_CR11","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.2337\/dc23-0628","volume":"46","author":"G Tsatsaris","year":"2023","unstructured":"Tsatsaris G, Rajamand Ekberg N, Fall T, Catrina S-B (2023) Prevalence of Charcot foot in subjects with diabetes: a nationwide cohort study. Diabetes Care 46(12):e217\u2013e218. https:\/\/doi.org\/10.2337\/dc23-0628","journal-title":"Diabetes Care"},{"issue":"01","key":"6271_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1055\/s-0033-1358483","volume":"122","author":"P Nehring","year":"2014","unstructured":"Nehring P, Mrozikiewicz-Rakowska B, Maroszek P et al (2014) Risk factors of Charcot neuroarthropathy development in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 122(01):31\u201334. https:\/\/doi.org\/10.1055\/s-0033-1358483","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"12","key":"6271_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11892-014-0561-6","volume":"14","author":"JV Mascarenhas","year":"2014","unstructured":"Mascarenhas JV, Jude EB (2014) The Charcot foot as a complication of diabetic neuropathy. Curr Diab Rep 14(12):561. https:\/\/doi.org\/10.1007\/s11892-014-0561-6","journal-title":"Curr Diab Rep"},{"issue":"9","key":"6271_CR14","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1302\/0301-620x.98b9.37038","volume":"98-B","author":"K Trieb","year":"2016","unstructured":"Trieb K (2016) The Charcot foot. Bone Joint J 98-B(9):1155\u20131159. https:\/\/doi.org\/10.1302\/0301-620x.98b9.37038","journal-title":"Bone Joint J"},{"issue":"1","key":"6271_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cpm.2007.10.001","volume":"25","author":"RG Frykberg","year":"2008","unstructured":"Frykberg RG, Belczyk R (2008) Epidemiology of the Charcot foot. Clin Podiatr Med Surg 25(1):17\u201328. https:\/\/doi.org\/10.1016\/j.cpm.2007.10.001","journal-title":"Clin Podiatr Med Surg"},{"issue":"10","key":"6271_CR16","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.2337\/dc10-0636","volume":"33","author":"NL Petrova","year":"2010","unstructured":"Petrova NL, Edmonds ME (2010) A prospective study of calcaneal bone mineral density in acute Charcot osteoarthropathy. Diabetes Care 33(10):2254\u20132256. https:\/\/doi.org\/10.2337\/dc10-0636","journal-title":"Diabetes Care"},{"issue":"4","key":"6271_CR17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.11622\/smedj.2016074","volume":"57","author":"AA Fauzi","year":"2016","unstructured":"Fauzi AA, Chung TY, Latif LA (2016) Risk factors of diabetic foot Charcot arthropathy: a case-control study at a Malaysian tertiary care centre. Singapore Med J 57(4):198\u2013203. https:\/\/doi.org\/10.11622\/smedj.2016074","journal-title":"Singapore Med J"},{"key":"6271_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1590\/2359-3997000000042","volume":"59","author":"MBdM N\u00f3brega","year":"2015","unstructured":"N\u00f3brega MBdM, Aras R, Netto EM et al (2015) Risk factors for Charcot foot. Arch Endocrinol Metab 59:226\u2013230. https:\/\/doi.org\/10.1590\/2359-3997000000042","journal-title":"Arch Endocrinol Metab"},{"issue":"5","key":"6271_CR19","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2337\/diacare.27.5.1235-a","volume":"27","author":"NL Petrova","year":"2004","unstructured":"Petrova NL, Foster AVM, Edmonds ME (2004) Difference in presentation of Charcot osteoarthropathy in type 1 compared with type 2 diabetes. Diabetes Care 27(5):1235\u20131236. https:\/\/doi.org\/10.2337\/diacare.27.5.1235-a","journal-title":"Diabetes Care"},{"issue":"3","key":"6271_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101563","volume":"34","author":"BM Schmidt","year":"2020","unstructured":"Schmidt BM (2020) Clinical insights into Charcot foot. Best Pract Res Clin Rheumatol 34(3):101563. https:\/\/doi.org\/10.1016\/j.berh.2020.101563","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"6271_CR21","unstructured":"Socialstyrelsen (2018) Socialstyrelsen: Nationella riktlinjer f\u00f6r diabetesv\u00e5rd - St\u00f6d f\u00f6r styrning och ledning. https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/artikelkatalog\/nationella-riktlinjer\/2018-10-25.pdf"},{"issue":"2","key":"6271_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth W, Abraira C, Moritz T et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360(2):129\u2013139. https:\/\/doi.org\/10.1056\/NEJMoa0808431","journal-title":"N Engl J Med"},{"key":"6271_CR23","doi-asserted-by":"publisher","unstructured":"(2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358(24):2545-2559. https:\/\/doi.org\/10.1056\/NEJMoa0802743","DOI":"10.1056\/NEJMoa0802743"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-024-06271-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-024-06271-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-024-06271-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T09:04:29Z","timestamp":1732784669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-024-06271-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["6271"],"URL":"https:\/\/doi.org\/10.1007\/s00125-024-06271-9","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"assertion":[{"value":"12 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Parts of the results of this study were presented as an abstract at the 9th international symposium on the diabetic foot in 2023 in den Haag, the Netherlands.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}},{"value":"The data that support the findings of this study are available from the National Board of Health and Welfare (Socialstyrelsen) and the NDR. Restrictions apply to the availability of these data, which were used under licence for the current study and therefore are not publicly available. Data are, however, available from the authors upon reasonable request and with permission of Socialstyrelsen and NDR.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Open access funding provided by Karolinska Institute. Funding for this study was received by the Stockholm County Research Council, von Kantzows Foundation, Kung Gustaf V\u2019s och Drottning Victorias Frimurarestifelse, Karolinska Institutet Research Foundation, Strategic Research Programme in Diabetes and Diabetesfonden. The funding sources did not influence the study design or the interpretation of the data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"TF is a member of the editorial board of Diabetologia. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"GT was involved in the conceptualisation, data curation, formal analysis, investigation, methodology, software, validation and visualisation, and writing and approval of the original and final draft. NRE and TF were involved in the investigation, methodology, supervision and validation, and reviewing, editing and approval of the original and the final draft. S-BC was involved in the conceptualisation, funding acquisition, investigation, methodology, project administration, resource finding, supervision and validation, and reviewing, editing and approval of the original and the final draft. GT, NRE and S-BC are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}